| 前收市價 | 5.48 |
| 開市 | 5.36 |
| 買盤 | 5.40 x 100 |
| 賣出價 | 5.47 x 100 |
| 今日波幅 | 5.29 - 5.52 |
| 52 週波幅 | 2.09 - 8.17 |
| 成交量 | |
| 平均成交量 | 197,243 |
| 市值 | 145.669M |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -5.06 |
| 業績公佈日 | 2024年8月06日 - 2024年8月12日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 19.25 |
ZacksWill Femasys Inc. (FEMY) Report Negative Q1 Earnings? What You Should Know
Femasys (FEMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksAnalysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look Out for
Syros Pharmaceuticals (SYRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksThe Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals are part of the Zacks top Analyst Blog.
